Overview
For patients with lung cancer or pulmonary nodules requiring surgery, the surgical approach and perioperative care philosophy determine not only oncological outcomes, but also how quickly the patient recovers and returns to normal life. Shanghai's leading thoracic surgeons have pioneered a "minimally invasive — precision — rapid recovery" approach that combines the smallest possible surgical footprint with meticulous technique and evidence-based enhanced recovery protocols — getting patients back on their feet faster without compromising cancer control.
China Medical Concierge Shanghai (CMCS) connects international patients with Shanghai's top thoracic surgeons, providing end-to-end support from remote consultation through to post-treatment follow-up.
Understanding Lung Cancer & Pulmonary Nodules
When Is Surgery Needed?
Surgery is the primary curative treatment for early-stage non-small cell lung cancer (NSCLC) and is also used for selected patients with locally advanced disease after neoadjuvant therapy. Surgery may also be indicated for:
- Pulmonary nodules with high malignancy risk that require resection for definitive diagnosis and treatment
- Oligometastatic disease — selected patients with limited metastatic disease where surgical resection of metastases may improve outcomes
- Diagnostic resection — when non-invasive biopsy is not feasible or inconclusive
Common Presentations
- Incidental pulmonary nodule found on CT scan (often asymptomatic)
- Ground-glass opacity (GGO) or part-solid nodule on LDCT screening
- Persistent cough, haemoptysis, or chest pain
- Unexplained weight loss and fatigue
Risk Factors
- Smoking and secondhand smoke exposure
- Radon gas and occupational exposures
- Air pollution and family history of lung cancer
- Prior lung disease (COPD, pulmonary fibrosis)
The "Minimally Invasive — Precision — Rapid Recovery" Philosophy
Minimally Invasive Surgery
Minimally invasive thoracic surgery — using video-assisted thoracoscopic surgery (VATS) or robotic-assisted techniques — achieves equivalent oncological outcomes to open surgery with significantly less pain, smaller incisions, lower complication rates, shorter hospital stay, and faster return to normal activity. At leading Shanghai centers, minimally invasive approaches are used for the vast majority of lung cancer resections.
Precision Surgical Technique
Precision in thoracic surgery means more than just small incisions. It encompasses:
- Anatomical accuracy — precise identification and preservation of critical structures (vessels, bronchi, nerves)
- Oncological completeness — ensuring adequate resection margins and systematic lymph node dissection
- Individualized surgical planning — selecting the right operation (lobectomy, segmentectomy, or wedge resection) for each patient based on tumor size, location, and lung function
- Intraoperative judgment — adapting the surgical approach in real time based on findings
Rapid Recovery (ERAS) Protocols
Enhanced Recovery After Surgery (ERAS) protocols are evidence-based perioperative care pathways that minimize surgical stress, optimize pain management, encourage early mobilization, and accelerate return to normal function. Key elements include:
- Preoperative optimization — nutritional support, respiratory physiotherapy, and smoking cessation
- Minimized fasting and early oral intake after surgery
- Multimodal analgesia — reducing opioid use and enabling earlier mobilization
- Early removal of chest drains and urinary catheters
- Structured early mobilization program
- Discharge planning from day of admission
ERAS protocols, combined with minimally invasive surgery, have reduced average hospital stays for lung cancer resection from 7–10 days to 3–5 days at leading centers — a significant benefit for international patients traveling to Shanghai for treatment.
Comprehensive Treatment Integration
Surgery is rarely the end of lung cancer treatment. Comprehensive treatment integrates surgery with:
- Adjuvant targeted therapy — osimertinib for EGFR-mutant stage IB-IIIA NSCLC (ADAURA trial)
- Adjuvant immunotherapy — atezolizumab or pembrolizumab for selected stage IB-IIIA NSCLC
- Adjuvant chemotherapy — for stage II-IIIA NSCLC
- Neoadjuvant chemoimmunotherapy — for locally advanced resectable disease
Why Choose Tongji Hospital for Lung Cancer Surgery?
- "Minimally invasive — precision — rapid recovery" philosophy — a patient-centered surgical approach that prioritizes both oncological outcomes and quality of life
- Experienced thoracic surgery department — high-volume lung cancer and pulmonary nodule surgery program
- Comprehensive treatment integration — surgery coordinated with medical oncology and radiation oncology for optimal adjuvant treatment planning
- Tongji University academic medical center — access to clinical research and novel treatment approaches
- Cost-effective world-class care — significantly lower cost than equivalent treatment in the US, UK, or Singapore
Featured Specialist: Dr. Zhou Yongxin — Tongji Hospital, Tongji University
Dr. Zhou Yongxin (周永新) is a Chief Physician and Director of the Department of Thoracic Surgery at Tongji Hospital, Tongji University — one of Shanghai's major academic medical centers. He is the champion of the "minimally invasive — precision — rapid recovery" (微创-精细-快速康复) surgical philosophy at Tongji Hospital, which he has implemented across the department's lung cancer and pulmonary nodule surgery program.
Minimally Invasive Thoracic Surgery Leadership
As Director of Thoracic Surgery, Dr. Zhou has led the adoption and refinement of minimally invasive surgical techniques for lung cancer and pulmonary nodule resection at Tongji Hospital. His commitment to the smallest possible surgical footprint — combined with meticulous precision and comprehensive ERAS-based recovery protocols — reflects a patient-centered philosophy that prioritizes both cancer control and quality of life.
Clinical Expertise
- VATS lobectomy and segmentectomy — minimally invasive resection for lung cancer and high-risk pulmonary nodules
- Pulmonary nodule surgical management — individualized surgical planning for GGOs, part-solid nodules, and solid nodules
- Rapid recovery (ERAS) protocols — evidence-based perioperative care to minimize hospital stay and accelerate recovery
- Comprehensive treatment integration — surgery coordinated with adjuvant targeted therapy, immunotherapy, and chemotherapy
- Complex thoracic surgery — locally advanced lung cancer requiring extended resection or vascular reconstruction
For international patients, Dr. Zhou's team offers remote pre-consultation review of CT scans, HRCT, PET-CT, and pathology, enabling a precise surgical plan and recovery timeline to be developed before arrival in Shanghai.
How CMCS Supports Your Journey
CMCS is not a hospital — we are your dedicated medical concierge, providing a trusted bridge between international patients and Shanghai's finest cancer specialists.
Our services include:
- ✅ Direct appointment coordination with Dr. Zhou Yongxin and the Tongji Hospital thoracic surgery team
- ✅ CT, HRCT, PET-CT, and pathology translation and pre-consultation review
- ✅ Second opinion facilitation
- ✅ Hospital admission and surgical scheduling support
- ✅ Accommodation and logistics coordination in Shanghai
- ✅ Post-treatment follow-up and remote check-in support
Contact CMCS
If you or a loved one has been diagnosed with lung cancer or has a pulmonary nodule requiring surgical assessment, our team is ready to help.
📧 Email: contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 Website: www.medicalsh.com
CMCS — China Medical Concierge Shanghai. Connecting international patients with Shanghai's finest specialists.
0 則留言